{
  "meta": {
    "title": "Obstetrics_And_Gynecology_Recall_Test",
    "url": "https://brainandscalpel.vercel.app/obstetrics-and-gynecology-recall-test-3eb2d857.html",
    "scrapedAt": "2025-11-30T11:10:45.311Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Fibroid uterus</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrial polyp</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrial carcinoma</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Leiomyosarcoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old woman presents with postmenopausal bleeding. Transvaginal ultrasonography with Color Doppler reveals the finding shown in the image below. What is the most likely diagnosis?<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/1Q.png\"></span></p>",
      "unique_key": "Q289418",
      "question_audio": null,
      "question_video": null,
      "map_id": 289418,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The presence of a well-defined mass within the endometrial cavity, along with a <strong>single feeding vessel</strong> on color Doppler, is a classic finding suggestive of an <strong>endometrial polyp</strong>.</p><br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/1E.png\"><p><strong>Endometrial Polyps:</strong></p><ul><li>Localized overgrowths of endometrial tissue composed of glands, fibrous stroma, and surface epithelium within the uterine cavity.</li><li><strong>Risk Factors:</strong><ul><li>Advancing age (especially postmenopausal women)</li><li>Obesity</li><li>Use of tamoxifen</li><li>Diabetes mellitus</li></ul></li><li><strong>Clinical Features:</strong><ul><li>Irregular uterine bleeding (can occur in both premenopausal and postmenopausal women)</li><li>Intermenstrual or prolonged menstrual bleeding</li><li>Excess vaginal discharge</li><li>Contact bleeding</li><li>Infertility or early pregnancy loss in young women (when multiple polyps are present)</li></ul></li><li><strong>Diagnosis:</strong><ul><li><strong>Transvaginal ultrasound (TVS):</strong> Ideal in the early menstrual cycle for better visualization</li><li><strong>Color Doppler:</strong> Helps differentiate polyps from fibroids; polyps typically show a single central vascular stalk</li><li><strong>Saline infusion sonography (SIS):</strong> Enhances cavity outline to detect small lesions</li><li><strong>Hysteroscopy:</strong> Gold standard for diagnosis and simultaneous removal</li></ul></li><li><strong>Management:</strong><ul><li><strong>Asymptomatic, low-risk cases:</strong> May be monitored</li><li><strong>Symptomatic cases or high-risk features</strong> (e.g., postmenopausal bleeding, large size, tamoxifen use):<ul><li>Hysteroscopic polypectomy is the treatment of choice</li></ul></li></ul></li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Uterine fibroids</strong> <strong>(Option A): </strong>Uterine fibroids are solid muscular tumors that usually arise within the uterine wall; they lack the typical single feeding vessel seen on Doppler in endometrial polyps and are less commonly associated with postmenopausal bleeding.</p><p><strong>Endometrial carcinoma</strong> <strong>(Option C): </strong>Although a common cause of postmenopausal bleeding, endometrial carcinoma generally appears as irregular endometrial thickening or diffuse masses on ultrasound, not as a well-defined mass with a feeding vessel.</p><p><strong>Leiomyosarcoma</strong> <strong>(Option D):</strong> This rare uterine cancer presents as a large, irregular, heterogeneous mass, often with areas of necrosis or hemorrhage, rather than a small, well-defined, intracavitary lesion with a feeding vessel.</p>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Fothergill surgery</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">McCall culdoplasty</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Leforte's repair</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Hysterectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old woman, P2 L2, presents with uterine prolapse associated with cervical elongation. She expresses a desire to retain her uterus and preserve future fertility. Which of the following is the most appropriate surgical option for this patient?</span></p>",
      "unique_key": "Q289419",
      "question_audio": null,
      "question_video": null,
      "map_id": 289419,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>In young women with uterine prolapse and cervical elongation who wish to preserve the uterus, <strong>Fothergill surgery</strong> is the preferred uterine-sparing procedure.</p><p><strong>Fothergill Surgery (Manchester Operation):</strong></p><ul><li><strong>Indication:</strong><ul><li>Uterine prolapse with cervical elongation</li><li>Women wishing to preserve fertility</li></ul></li><li><strong>Steps:</strong><ul><li>Dilatation and curettage (if required)</li><li>Amputation of the elongated cervix</li><li>Plication (tightening) of <strong>Mackenrodt&rsquo;s (cardinal) ligaments</strong> to provide support</li><li>Anterior colporrhaphy (repair of the anterior vaginal wall)</li><li>Colpoperineorrhaphy (reinforcement of the perineal body)</li></ul></li><li><strong>Complications:</strong><ul><li>Cervical stenosis</li><li>Cervical incompetence</li><li>Fibrosis at the surgical site</li><li>Urinary retention</li></ul></li></ul><p><strong>Explanation of other options:</strong></p><p><strong>McCall Culdoplasty (Option B): </strong>This is performed to support the vaginal vault and prevent enterocele, usually done at the time of or after hysterectomy, not suitable for women who wish to preserve the uterus.</p><p><strong>LeForte's repair (Option C): </strong>A partial colpocleisis procedure intended for elderly women or those unfit for major surgery; it results in vaginal closure, making it inappropriate for women desiring reproductive function.</p><p><strong>Hysterectomy (Option D): </strong>Involves complete removal of the uterus, eliminating reproductive potential, thus not recommended for young women with cervical elongation who wish to preserve fertility.</p>",
      "correct_choice_id": 11,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Leaving the IUCD inside and continuing pregnancy with prophylactic antibiotics</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Leave the IUCD inside and continue pregnancy</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Remove the IUCD immediately and continue with pregnancy</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Termination of pregnancy due to the risk of infection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old woman with a confirmed 10-week intrauterine pregnancy presents with an intrauterine contraceptive device (IUCD) in place. The IUCD thread is visible. She expresses her desire to continue the pregnancy. What is the next best step?</span></p>",
      "unique_key": "Q289420",
      "question_audio": null,
      "question_video": null,
      "map_id": 289420,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The presence of a visible IUCD thread in early pregnancy requires<strong> immediate removal </strong>to reduce the risk of miscarriage, infection, and preterm labor while <strong>allowing the pregnancy to continue safely.</strong></p><p><strong>Risks of Pregnancy with IUCD:</strong></p><ul><li>Increased risk of miscarriage</li><li>Preterm birth</li><li>Intra-amniotic infection or septic abortion</li><li>Intrauterine growth restriction (IUGR)</li></ul><p><strong>Management of IUCD in Pregnancy:</strong></p><ol><li><strong>Confirm Pregnancy:</strong><ul><li>Perform a urine pregnancy test</li><li>Confirm with ultrasound to assess gestational age and rule out ectopic pregnancy</li></ul></li><li><strong>Assess IUCD Position:</strong><ul><li>Use a transvaginal or abdominal ultrasound to check:<ul><li>Correct IUCD placement</li><li>Partial expulsion</li><li>Displacement</li></ul></li></ul></li><li><strong>IUCD String Visibility:</strong><ul><li><strong>Strings Visible:</strong><ul><li>Gently remove the IUCD by pulling the strings after explaining the potential risks to the mother</li></ul></li><li><strong>Strings Not Visible:</strong><ul><li>If the IUCD is inside the uterus, options include:<ul><li>Termination of pregnancy</li><li>Ultrasound-guided removal if the IUCD is not at the uterine fundus</li><li>Continuation of pregnancy with IUCD in place (only if IUCD is at the fundus, with caution)</li></ul></li></ul></li></ul></li></ol><p><strong>Explanation of other options:</strong></p><p><strong>Leaving the IUCD inside and continuing pregnancy with prophylactic antibiotics (Option A):</strong> Even with antibiotics, keeping the IUCD in place increases the risk of miscarriage, infection, and preterm labor, especially if the thread is visible and the device is accessible for removal.</p><p><strong>Leave the IUCD inside and continue pregnancy</strong> <strong>(Option B): </strong>This is not recommended when the thread is visible in early pregnancy, as prompt removal reduces complications and allows for a safer pregnancy.</p><p><strong>Termination of pregnancy due to the risk of infection (Option D): </strong>Termination is not mandatory; it may be considered only if the woman opts for it, but in this case, she wishes to continue the pregnancy, so removal of the IUCD is the preferred option.</p>",
      "correct_choice_id": 23,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage II B</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage II A</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage III B</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage III A</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient diagnosed with cervical cancer undergoes evaluation. Examination reveals tumor involvement of the pelvic sidewall along with hydronephrosis. What is the most appropriate stage of this cancer?</span></p>",
      "unique_key": "Q289421",
      "question_audio": null,
      "question_video": null,
      "map_id": 289421,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>According to <strong>FIGO staging</strong>, <strong>Stage III B</strong> cervical cancer is characterized by tumor extension to the <strong>pelvic sidewall</strong> and/or the presence of <strong>hydronephrosis</strong> or a <strong>non-functioning kidney</strong> due to tumor compression or infiltration.</p><br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/4E.png\"><p><strong>Reference:</strong> <a href=\"https://radiopaedia.org/articles/cervical-cancer-staging-1\">Cervical cancer (staging)</a></p>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Mifepristone and Misoprostol</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Dinoprostone</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxytocin</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Intrauterine hyperosmolar saline</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old woman with a confirmed 10-week intrauterine pregnancy requests medical termination. What is the most appropriate method?</span></p>",
      "unique_key": "Q289422",
      "question_audio": null,
      "question_video": null,
      "map_id": 289422,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<ul><li>For pregnancies up to <strong>10 weeks gestation</strong>, the standard and most effective method for medical abortion is <strong>Mifepristone 200 mg orally</strong>, followed by <strong>Misoprostol 800 mcg vaginally</strong> after 24 hours.</li><li><strong>Mifepristone</strong> blocks progesterone, weakening the uterine lining, while <strong>Misoprostol</strong> induces uterine contractions to expel the pregnancy.</li></ul><br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/5E.png\"><p><strong>Explanation of other options:</strong></p><p><strong>Dinoprostone (Option B):</strong> This prostaglandin is primarily used for labor induction or second-trimester abortion, not for medical abortion at 10 weeks of gestation.</p><p><strong>Oxytocin (Option C):</strong> Used to induce labor or manage postpartum hemorrhage, but it is ineffective for first-trimester medical termination of pregnancy.</p><p><strong>Intrauterine Hyperosmolar Saline (Option D): </strong>An outdated, invasive method used for second-trimester abortions; it is not used for early pregnancy termination and carries more risks.</p>",
      "correct_choice_id": 41,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Transverse vaginal septum</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Vaginal atresia</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Imperforate hymen</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Cervical agenesis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 16-year-old girl presents with cyclical lower abdominal pain for the past few months. She has not yet attained menarche. On examination, there is a midline suprapubic mass. A per-rectal examination reveals a swelling on the anterior aspect. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q289423",
      "question_audio": null,
      "question_video": null,
      "map_id": 289423,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The girl's cyclical abdominal pain, primary amenorrhea, and suprapubic swelling are classic signs of <strong>cryptomenorrhea</strong> due to <strong>imperforate hymen</strong>, the most common obstructive anomaly of the female genital tract.</p><p><strong>Cryptomenorrhea:</strong></p><ul><li><strong>Causes:</strong><ul><li><strong>Congenital:</strong><ul><li>Imperforate hymen</li><li>Transverse vaginal septum</li><li>Atresia of upper third of vagina and cervix</li></ul></li><li><strong>Acquired:</strong><ul><li>Cervical stenosis following:<ul><li>Amputation of the cervix</li><li>Deep cauterization</li><li>Conization procedures</li></ul></li><li>Secondary vaginal atresia due to neglected or difficult vaginal delivery</li></ul></li></ul></li><li><strong>Clinical Features:</strong><ul><li><strong>Common age:</strong> <strong>13-15 years</strong> (especially in congenital cases)</li><li><strong>Symptoms:</strong><ul><li>Cyclical lower abdominal pain</li><li>Urinary retention (if hematocolpos present)</li></ul></li><li><strong>Physical Examination:</strong><ul><li><strong>Abdomen:</strong> Uniform, globular mass in the hypogastrium</li><li><strong>Vulva:</strong> Bulging hymen.<img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/6E.png\"> </li><li><strong>Rectal exam:</strong> Full vagina and palpable uterine mass</li></ul></li></ul></li><li><strong>Management:</strong><ul><li><strong>Imperforate Hymen</strong>: Cruciate incision with drainage of collected blood</li><li><strong>Cervical Stenosis</strong>: Gentle cervical dilatation to relieve obstruction</li></ul></li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Transverse vaginal septum (Option A):</strong> This is a band of tissue within the vaginal canal that causes obstruction, but typically does not produce a prominent suprapubic mass or anterior swelling on rectal examination.</p><p><strong>Vaginal atresia (Option B):</strong> Absence or underdevelopment of the vaginal canal can cause cryptomenorrhea, but it rarely presents with a midline suprapubic bulge, and examination usually reveals an absent or blind vaginal pouch.</p><p><strong>Cervical agenesis (Option D): </strong>Absence of the cervix results in primary amenorrhea, but there is usually no suprapubic swelling or bulging on rectal examination, and it is often associated with other Mullerian anomalies.</p>",
      "correct_choice_id": 53,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Ovarian hyperstimulation syndrome</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Polycystic ovarian syndrome</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Theca lutein cysts</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Granulosa cell tumor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 24-year-old woman undergoing infertility treatment with human menopausal gonadotropins presents with sudden-onset abdominal pain, nausea, vomiting, and shortness of breath. An ultrasound image of her pelvis is taken and is shown below. What is the most likely diagnosis?<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/7Q.png\"></span></p>",
      "unique_key": "Q289424",
      "question_audio": null,
      "question_video": null,
      "map_id": 289424,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The combination of ovarian stimulation, sudden abdominal symptoms, respiratory difficulty, and the classic <strong>spoke-wheel pattern</strong> on ultrasound strongly suggests <strong>Ovarian hyperstimulation syndrome (OHSS)</strong>. This condition is a recognized complication of ovulation induction therapies like <strong>human menopausal gonadotropin (hMG)</strong>.</p><p><strong>Ovarian Hyperstimulation Syndrome (OHSS):</strong></p><ul><li>A complication of ovulation induction, typically following the use of medications like <strong>human menopausal gonadotropin (hMG).</strong></li><li>Caused by excessive ovarian response leading to enlarged ovaries and increased vascular permeability.</li><li>Results in fluid shift from the intravascular compartment to third spaces (e.g., abdomen, chest).</li><li><strong>Clinical Features:</strong><ul><li>Abdominal pain and bloating</li><li>Ascites (fluid accumulation in the abdomen)</li><li>Gastrointestinal symptoms (nausea, vomiting)</li><li>Breathing difficulty (due to pleural effusion)</li><li>Reduced urine output (oliguria)</li><li>Hemoconcentration (raised hematocrit)</li><li>Risk of thromboembolic events</li></ul></li><li><strong>Investigations:</strong><ul><li><strong>Ultrasound findings:</strong><ul><li>Enlarged ovaries</li><li>Multiple follicular cysts arranged in a <strong>spoke-wheel pattern</strong></li><li>Presence of ascites<img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/7E.png\"> </li></ul></li></ul></li><li><strong>Management:</strong><ul><li>Supportive care (symptom monitoring and fluid management)</li><li>Paracentesis in cases of severe abdominal discomfort or respiratory compromise</li><li>Careful fluid balance to avoid renal, hepatic, or pulmonary complications</li><li>Thromboprophylaxis to reduce the risk of venous thromboembolism</li></ul></li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Polycystic ovarian syndrome (Option B):</strong> PCOS is a chronic hormonal disorder with menstrual irregularities, acne, and hirsutism. It does not present with sudden abdominal pain, breathlessness, or spoke-wheel appearance after ovarian stimulation.</p><p><strong>Theca lutein cysts (Option C): </strong>These cysts are linked to high &beta;-hCG levels, typically seen in molar pregnancy or multiple gestations. The patient has no evidence of elevated hCG or gestational trophoblastic disease, making this unlikely.</p><p><strong>Granulosa cell tumours (Option D):</strong> This is a rare ovarian tumour that usually presents with estrogen-related symptoms like menstrual irregularities or postmenopausal bleeding. It is not associated with fertility treatments or the acute presentation seen in this case.</p>",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Abruptio placenta</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Fetal hydrocephalus</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Polyhydramnios</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Feto-maternal ascites</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 36-week pregnant woman presents with breathlessness and marked abdominal distension. Fetal movements are reported as normal. On examination, fetal parts are difficult to palpate, the fetal heart sounds are present but muffled, and the symphysis-fundal height measures 41 cm. The abdomen feels tense but non-tender. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q289425",
      "question_audio": null,
      "question_video": null,
      "map_id": 289425,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The clinical features of enlarged symphysis-fundal height, difficulty in palpating fetal parts, and muffled fetal heart sounds point towards the diagnosis of <strong>Polyhydramnios</strong>.</p><p><strong>Polyhydramnios:</strong></p><ul><li>Refers to the excessive accumulation of amniotic fluid during pregnancy.</li><li><strong>Mechanisms of Excess Amniotic Fluid Production:</strong><ul><li>Leakage of fluid from exposed fetal meninges</li><li>Impaired fetal swallowing reflex</li><li>Reduced fetal antidiuretic hormone activity &rarr; increased fetal urine output</li></ul></li><li><strong>Severity Classification (Based on Amniotic Fluid Index - AFI):</strong><ul><li><strong>Mild:</strong> AFI 25 to 29.9 cm</li><li><strong>Moderate:</strong> AFI 30 to 34.9 cm</li><li><strong>Severe:</strong> AFI &ge; 35 cm</li></ul></li><li><strong>Causes:</strong></li></ul><br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/8E.png\"><p><strong>Explanation of other options:</strong></p><p><strong>Abruptio placenta</strong> <strong>(Option A): </strong>Usually presents with sudden-onset abdominal pain, vaginal bleeding, and a firm, tender uterus. This patient has no vaginal bleeding or uterine tenderness, making this diagnosis unlikely.</p><p><strong>Fetal hydrocephalus (Option B): </strong>Leads to an enlarged fetal head, which may complicate delivery. It does not cause marked abdominal distension or difficulty palpating fetal parts during antenatal examination.</p><p><strong>Feto-maternal ascites (Option D):</strong> Characterized by abnormal fluid collection within the fetal and maternal compartments, often with generalized fetal edema or skin changes. These additional signs are not seen in this patient, making it an unlikely diagnosis.</p>",
      "correct_choice_id": 73,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral methotrexate</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Single-dose methotrexate injection</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Serial methotrexate + leucovorin rescue</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Salpingectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman presents with 6 weeks of amenorrhea, vaginal bleeding, and mild lower abdominal pain. Her urine pregnancy test shows a faint positive result. Serum &beta;-hCG is measured at 2800 IU/L. A transvaginal ultrasound reveals a left-sided adnexal mass measuring 3 x 2.5 cm. She is hemodynamically stable. What is the most appropriate next step in management?</span></p>",
      "unique_key": "Q289426",
      "question_audio": null,
      "question_video": null,
      "map_id": 289426,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The patient has a small, <strong>unruptured ectopic pregnancy</strong> with no fetal cardiac activity, an hCG level below 3000 IU/L, and is hemodynamically stable. In such cases, <strong>medical management with a single intramuscular injection of methotrexate</strong> is considered the treatment of choice.</p><br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/9E.png\"><p><strong>Explanation of other options:</strong></p><p><strong>Oral methotrexate (Option A): </strong>Methotrexate is not given orally for ectopic pregnancy as this route is unreliable for achieving the therapeutic effect. The standard and effective route is intramuscular injection.</p><p><strong>Serial methotrexate with leucovorin rescue</strong> <strong>(Option C): </strong>This regimen is generally reserved for complex or high-risk ectopic pregnancies or when single-dose methotrexate fails. In this stable patient with low hCG and a small mass, single-dose methotrexate is sufficient.</p><p><strong>Salpingectomy (Option D): </strong>Salpingectomy is a surgical option used in cases of ruptured ectopic pregnancy, hemodynamic instability, large mass, or high hCG levels. This patient is stable with low hCG and a small mass, so surgery is not required.</p>",
      "correct_choice_id": 82,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Septate uterus</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Uterine didelphys</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Bicornuate uterus</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Unicornuate uterus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 20-year-old woman undergoing evaluation for primary infertility undergoes a hysterosalpingogram (HSG). The findings are shown in the image below. What is the most likely uterine anomaly seen in this image?<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/10Q.png\"></span></p>",
      "unique_key": "Q289427",
      "question_audio": null,
      "question_video": null,
      "map_id": 289427,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The image demonstrates features consistent with a <strong>septate uterus</strong>, a congenital uterine anomaly resulting from incomplete resorption of the septum between the two M&uuml;llerian ducts.</p><p><strong>Key HSG Features of Septate Uterus:</strong></p><ul><li>Narrow, elongated endometrial cavity</li><li>Widely spaced, but not markedly divergent horns</li><li><strong>Intercornual angle &lt;75&deg;</strong></li><li>Normal external uterine contour (differentiating it from a bicornuate uterus)</li></ul><br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/10E.png\"><br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/10E1.png\">",
      "correct_choice_id": 91,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Spiral artery by villous trophoblasts</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Radial artery by cytotrophoblasts</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Spiral artery by extravillous trophoblasts</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Arcuate artery by extravillous trophoblasts</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant woman without any known medical conditions develops preeclampsia. She wants to understand the cause of her condition. The doctor explains that it is due to the failure of the invasion of which of the following?</span></p>",
      "unique_key": "Q289428",
      "question_audio": null,
      "question_video": null,
      "map_id": 289428,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>Preeclampsia occurs due to abnormal placental development, specifically the failure of <strong>extravillous trophoblasts</strong> to properly invade and remodel the <strong>spiral arteries</strong>.</p><p><strong>Normal Spiral Artery Remodeling in Pregnancy:</strong></p><ul><li>Spiral arteries supply blood to the endometrium and placenta.</li><li>During early pregnancy, extravillous trophoblasts invade these arteries, transforming them into large, low-resistance vessels.</li><li>This remodeling happens in two phases:<ul><li><strong>First phase (10-12 weeks):</strong> Trophoblasts invade the decidual portion of spiral arteries.</li><li><strong>Second phase (16-18 weeks):</strong> Deeper invasion reaches the myometrial portion.</li></ul></li><li>The remodeled arteries ensure adequate blood supply to the growing placenta and fetus.</li></ul><p><strong>In Preeclampsia:</strong></p><ul><li>The second phase of trophoblastic invasion is incomplete or fails.</li><li>Spiral arteries remain narrow and high-resistance.</li><li>Reduced placental blood flow leads to placental ischemia.</li><li>Ischemic placenta releases factors into the maternal circulation, causing:<ul><li>Endothelial dysfunction</li><li>Hypertension</li><li>Multisystem organ involvement</li></ul></li></ul><br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/11E.png\">",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Methotrexate with folinic acid</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Methotrexate</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">EMACO regimen</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Hysterectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old woman is diagnosed with choriocarcinoma following a molar pregnancy evacuation done six months ago. She now has metastases to the lungs, spleen, and kidneys. Her pre-treatment serum &beta;-hCG level is 10,000 IU/mL, a uterine mass measuring 6 cm, and she has not responded to prior treatment with methotrexate. What is the most appropriate next step in management?</span></p>",
      "unique_key": "Q289429",
      "question_audio": null,
      "question_video": null,
      "map_id": 289429,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The patient has <strong>stage IV disease</strong> with metastases beyond the lungs and a <strong>WHO prognostic score of 8</strong>, both indicating high-risk disease. According to guidelines, stage IV or stages II/III with a score &gt;6 require treatment with the <strong>EMACO regimen</strong>, which is the standard for high-risk invasive mole and choriocarcinoma.</p><p>&beta;-hCG 10,000 IU/mL (Score 2), spleen/kidney metastases (Score 1), time since pregnancy &gt;6 months (Score 2), prior failed chemotherapy (Score 2), age &lt;40 (Score 0), total =<strong> 8.</strong></p><br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/12E.png\"><p>Low risk = WHO score of 0 to 6.</p><p>High risk = WHO score of &ge;7.</p><p><strong>Management of GTN Based on WHO Risk Score:</strong></p><ul><li><strong>Low-Risk (Score &le; 6):</strong><ul><li><strong>Treatment:</strong> Single-agent chemotherapy</li><li><strong>Preferred regimen:</strong><ul><li>Methotrexate</li><li>Folinic acid (administered on alternate days to reduce toxicity)</li></ul></li></ul></li><li><strong>High-Risk (Score &ge; 7):</strong><ul><li><strong>Treatment:</strong> Multi-agent chemotherapy</li><li><strong>Preferred regimen:</strong> <strong>EMACO regimen</strong>, which includes:<ul><li>Etoposide</li><li>Methotrexate</li><li>Actinomycin D</li><li>Cyclophosphamide</li><li>Oncovin (Vincristine)</li></ul></li></ul></li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Methotrexate with folinic acid (Option A): </strong>This is suitable for low-risk gestational trophoblastic neoplasia (GTN). It is inadequate for high-risk disease with distant metastases like in this patient.</p><p><strong>Methotrexate (Option B):</strong> Single-agent methotrexate is only used for low-risk cases. It is ineffective for high-risk, metastatic choriocarcinoma, especially after prior methotrexate failure.</p><p><strong>Hysterectomy (Option D): </strong>Surgery may help control localized uterine disease but does not treat distant metastases. In high-risk GTN with systemic spread, multi-agent chemotherapy is the treatment of choice.</p><p><strong>Reference:</strong> <a href=\"https://www.uptodate.com/contents/initial-management-of-high-risk-gestational-trophoblastic-neoplasia\">https://www.uptodate.com/contents/initial-management-of-high-risk-gestational-trophoblastic-neoplasia</a></p>",
      "correct_choice_id": 113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Stop warfarin and start LMWH</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Stop warfarin and start heparin</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Continue warfarin</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Stop warfarin, start LMWH and aspirin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 36-week pregnant woman with a history of mechanical mitral valve replacement is currently taking warfarin for anticoagulation. Her recent INR is 3. What is the most appropriate next step in her management?</span></p>",
      "unique_key": "Q289430",
      "question_audio": null,
      "question_video": null,
      "map_id": 289430,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>In a pregnant woman with a mechanical valve on<strong> warfarin</strong> is stopped at 36 weeks to allow clearance before delivery, with <strong>LMWH</strong> continued until labor or 12-24 hours before planned delivery.</p><p><strong>Warfarin Use in Pregnancy:</strong></p><ul><li>Warfarin crosses the placenta and is <strong>teratogenic</strong>, especially in the <strong>first trimester</strong>.</li><li>If the required warfarin dose is <strong>&lt; 5 mg/day</strong>, it may be continued in the first trimester after careful risk assessment.</li><li>If the dose is <strong>&ge; 5 mg/day</strong>, it should be replaced with <strong>low molecular weight heparin (LMWH)</strong> during the first trimester.</li><li>Near term, warfarin is stopped to reduce bleeding risk during delivery and restarted postpartum.</li></ul><p><strong>Heparin Use in Pregnancy:</strong></p><ul><li>Both <strong>unfractionated heparin (UFH)</strong> and <strong>LMWH</strong> do <strong>not cross the placenta</strong>, making them safer alternatives.</li><li><strong>LMWH</strong> is preferred over UFH for mechanical heart valves due to a lower risk of valve thrombosis.</li><li>UFH at full anticoagulation doses is often insufficient for valve thrombosis prevention.</li></ul><p><strong>Monitoring Requirements:</strong></p><ul><li><strong>PT/INR</strong> for warfarin therapy.</li><li><strong>Anti-Xa levels</strong> for LMWH, essential during pregnancy to ensure adequate anticoagulation.</li></ul><p><strong>Anticoagulation Approach in Pregnancy:</strong></p><ul><li><strong>First trimester:</strong> LMWH is preferred to avoid teratogenic risks.</li><li><strong>Second trimester onward:</strong> Warfarin may be resumed for better protection against valve thrombosis (if dose permits).</li><li><strong>Near term:</strong> Switch back to LMWH or UFH to minimize bleeding risk during delivery.</li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Stop warfarin and start heparin (Option B): </strong>LMWH is preferred over unfractionated heparin due to its longer half-life, once-daily dosing, and fewer side effects. If LMWH is unavailable, unfractionated heparin can be used as an alternative.</p><p><strong>Stop warfarin, start LMWH and aspirin (Option D): </strong>Low-dose aspirin (75-100 mg) may be considered in women with mechanical heart valves if additional risk factors (e.g., preeclampsia) are present, but it is not routinely required in this scenario.</p>",
      "correct_choice_id": 121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Sheehan syndrome</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothyroidism</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Premature ovarian failure</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Delayed blood transfusion reaction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26-year-old woman presents with complaints of tiredness and constipation for the past year. She reports a history of significant blood loss requiring multiple transfusions during childbirth four years ago. Since then, she has been unable to breastfeed and has not resumed menstruation. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q289431",
      "question_audio": null,
      "question_video": null,
      "map_id": 289431,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The patient's symptoms of fatigue, constipation, absence of menstruation, and inability to lactate, combined with a history of heavy postpartum bleeding, are classic features of <strong>Sheehan syndrome</strong>, a form of <strong>postpartum pituitary infarction </strong>due to ischemic damage from severe blood loss.</p><p><strong>Sheehan Syndrome:</strong></p><ul><li>Postpartum hypopituitarism is caused by ischemic necrosis of the pituitary gland following severe postpartum hemorrhage (PPH).</li><li><strong>Clinical Features:</strong><ul><li><strong>Early Symptoms:</strong><ul><li>Failure to lactate (due to prolactin deficiency)</li><li>Hypotension</li><li>Hypoglycemia</li><li>Fatigue</li></ul></li><li><strong>Later Symptoms:</strong><ul><li>Amenorrhea or oligomenorrhea</li><li>Features of hypothyroidism (weight gain, cold intolerance)</li><li>Adrenal insufficiency (fatigue, low blood pressure)</li><li>Decreased libido</li></ul></li></ul></li><li><strong>Diagnosis:</strong><ul><li>History of significant postpartum hemorrhage</li><li><strong>Hormonal evaluation:</strong><ul><li>Low prolactin</li><li>Low TSH</li><li>Low ACTH</li><li>Low LH and FSH</li><li>Low growth hormone</li></ul></li><li><strong>Imaging:</strong><ul><li>MRI showing an <strong>empty sella</strong> or reduced pituitary size</li></ul></li></ul></li><li><strong>Management:</strong><ul><li>Lifelong hormone replacement therapy:<ul><li>Glucocorticoids</li><li>Levothyroxine</li><li>Estrogen-progesterone (if uterus intact)</li><li>Growth hormone (if needed)</li></ul></li></ul></li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Hypothyroidism (Option B): </strong>While it can cause fatigue and constipation, it does not explain lactational failure or amenorrhea following postpartum hemorrhage, which are key features of Sheehan syndrome.</p><p><strong>Premature ovarian failure (Option C): </strong>Amenorrhea occurs in this condition, but it does not typically affect lactation, and there is no direct link to a history of severe postpartum bleeding.</p><p><strong>Delayed blood transfusion reaction (Option D):</strong> This presents with acute symptoms such as fever, chills, or jaundice shortly after transfusion, and does not explain chronic symptoms like amenorrhea or lactational failure.</p>",
      "correct_choice_id": 131,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Candidiasis</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Bacterial vaginosis</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Trichomoniasis</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Physiological</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old married woman who is eager to conceive visits the clinic with complaints of increased vaginal discharge. She denies any itching or foul odour. Her last menstrual period was 13 days ago. What is the most likely cause of her vaginal discharge?</span></p>",
      "unique_key": "Q289432",
      "question_audio": null,
      "question_video": null,
      "map_id": 289432,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>Increased vaginal discharge without itching or abnormal odour, occurring approximately 13 days after the last menstrual period, is consistent with <strong>physiological discharge associated with ovulation</strong>. On day 13 of a 28-day menstrual cycle, the discharge is likely due to<strong> increased estrogen levels </strong>at ovulation, resulting in clear, stretchy, egg-white-like cervical mucus that facilitates sperm transport.</p><p><strong>Physiological Vaginal Discharge (Leucorrhoea):</strong></p><ul><li>Increase in normal vaginal discharge without signs of infection or pathology.</li><li>Consistency and volume may vary with hormonal changes during the menstrual cycle.</li><li><strong>Common Physiological Causes:</strong><ul><li>Puberty</li><li>Ovulation (<strong>copious, clear, egg-white consistency</strong>)</li><li>Pregnancy</li><li>Pre-menstrual phase (may occur occasionally)</li></ul></li><li><strong>Source of Discharge:</strong><ul><li><strong>Cervical origin:</strong> Excessive mucoid secretion is visible at the external os on speculum examination</li><li><strong>Vaginal origin:</strong> Discharge from the vaginal walls</li></ul></li><li><strong>Characteristics of Normal Vaginal Discharge:</strong><ul><li>Clear or white</li><li>Odourless</li><li>Non-itchy</li><li>pH between <strong>3.8 to 4.2</strong></li><li>Not associated with infection or pathology</li></ul></li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Candidiasis (Option A):</strong> Usually causes thick, curd-like white discharge with intense itching and redness, which are not present in this case.</p><p><strong>Bacterial vaginosis (Option B):</strong> Typically presents with thin, greyish discharge and a fishy odour, neither of which is described here.</p><p><strong>Trichomoniasis (Option C):</strong> Causes frothy, yellow-green discharge with itching and vaginal irritation, which this patient does not report.</p>",
      "correct_choice_id": 144,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">G2P2</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">G3P2</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">G2P1</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">G3P1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old woman comes for a routine antenatal check-up during her second trimester. She had previously delivered healthy twins at full term four years ago. What is her correct obstetric score?</span></p>",
      "unique_key": "Q289433",
      "question_audio": null,
      "question_video": null,
      "map_id": 289433,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The correct obstetric score is <strong>G2P1</strong> as this is her second pregnancy, and her previous twin delivery counts as one parity, regardless of the number of babies born.</p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/16E.png\"><p><strong>Note:</strong> A <strong>twin pregnancy</strong> counts as <strong>one</strong> for both gravida and parity, even if more than one baby was delivered.</p><p><strong>Explanation of other options:</strong></p><p><strong>G2P2 (Option A)</strong>: Implies two previous deliveries beyond viability, but she had only one twin delivery, which counts as one parity.</p><p><strong>G3P2 (Option B)</strong>: Suggests three pregnancies and two deliveries, but she is only in her second pregnancy.</p><p><strong>G3P1 (Option D)</strong>: Indicates three pregnancies, whereas she has had only two (the previous twin pregnancy counts as one).</p>",
      "correct_choice_id": 153,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Take 4 pills now, continue the schedule, and use a barrier method of contraception.</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Take 1 pill now, continue the schedule, and use a barrier method of contraception.</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Take 1 pill now, use a barrier method, and consider emergency contraception in case of recent intercourse.</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Discard the pack and start a new pack with an alternate method of contraception.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 27-year-old woman, currently using oral contraceptive pills (OCPs) for contraception, reports that she has missed her pills on four different days over the last two weeks. She seeks advice at the primary health center. What is the best course of action?</span></p>",
      "unique_key": "Q289434",
      "question_audio": null,
      "question_video": null,
      "map_id": 289434,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>Missing <strong>three or more pills</strong> at any point in the cycle significantly reduces contraceptive effectiveness. In such situations, the current pill pack should be discarded, a new pack started immediately, and a <strong>backup contraceptive method</strong> (such as condoms) used for the next 7 days.</p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/17E.png\">",
      "correct_choice_id": 164,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Crown-rump length by USG</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Adding 280 days to the LMP</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Fundus examination</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Adding 256 days to the LMP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old woman, who has been on oral contraceptive pills for the past 6 months, presents with 6 weeks of missed periods. You are asked to determine the best method to assess her gestational age. What is the most reliable method to assess gestational age in this patient?</span></p>",
      "unique_key": "Q289435",
      "question_audio": null,
      "question_video": null,
      "map_id": 289435,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>CRL measured by ultrasound</strong> in early pregnancy is the most accurate method for determining gestational age, especially before <strong>14 weeks</strong>, with an accuracy of approximately <strong>5 to 7 days</strong>.</p><p><strong>Gestational Age Determination:</strong></p><ul><li>Calculated from the <strong>first day of the Last Menstrual Period (LMP)</strong>, expressed in completed weeks.</li><li>Early pregnancy ultrasound can be used to measure the embryo or fetus for gestational age estimation.</li><li>If the LMP is <strong>unknown</strong> or there is a <strong>discrepancy between LMP and ultrasound</strong>, the ultrasound findings are used to determine the <strong>Estimated Due Date (EDD)</strong>.</li></ul><p><strong>Ultrasound Parameters for Estimating Gestational Age:</strong></p><ul><li><strong>Crown-Rump Length (CRL):</strong><ul><li>Most precise method in the first trimester.</li><li>Best used before <strong>14 weeks</strong> of pregnancy.</li><li>Provides an accuracy of approximately <strong>5 to 7 days</strong>.</li></ul></li><li><strong>After 14 Weeks of Gestation, </strong>additional fetal measurements are used to estimate gestational age and fetal growth, including:<ul><li>Biparietal Diameter (BPD)</li><li>Head Circumference (HC)</li><li>Abdominal Circumference (AC)</li><li>Femur Length (FL)</li></ul></li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/18E.png\"><p>CRL: Crown-Rump Length, BPD: Biparietal Diameter, HC: Head Circumference, AC: Abdominal Circumference, FL: Femur Length</p><p><strong>Explanation of other options:</strong></p><p><strong>Adding 280 days to the LMP (Option B): </strong>This method assumes a regular 28-day cycle, which may not be reliable for women with irregular cycles or recent hormonal contraceptive use.</p><p><strong>Fundus examination (Option C): </strong>Palpating the uterine fundus is not accurate in early pregnancy and can be influenced by maternal factors like obesity or uterine position.</p><p><strong>Adding 256 days to the LMP (Option D): </strong>This is not a recognized method for dating pregnancy and lacks scientific validity.</p>",
      "correct_choice_id": 171,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin only</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin + heparin</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Heparin + steroids</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin+steroids</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant woman with a history of recurrent miscarriages undergoes evaluation, which reveals the presence of antiphospholipid antibodies. What is the most appropriate treatment to reduce her risk of pregnancy loss and complications?</span></p>",
      "unique_key": "Q289436",
      "question_audio": null,
      "question_video": null,
      "map_id": 289436,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The combination of <strong>recurrent miscarriages</strong> along with the detection of <strong>antiphospholipid antibodies</strong> suggests an underlying <strong>antiphospholipid antibody-related pregnancy complication</strong>. The most effective treatment to lower the risk of pregnancy loss and improve outcomes is a combination of <strong>low-dose aspirin and heparin</strong>.</p><p><strong>Antiphospholipid Antibody Syndrome (APLA Syndrome):</strong></p><ul><li>A thrombophilic disorder characterized by a tendency for venous and arterial thrombosis, often associated with pregnancy complications.</li><li><strong>Pathophysiology:</strong><ul><li>Antiphospholipid antibodies (APAs) or anti-&beta;2-glycoprotein I antibodies promote:<ul><li>Platelet aggregation</li><li>Endothelial dysfunction</li><li>Thrombus formation</li></ul></li><li>Other contributing factors:<ul><li>Decreased prostaglandin E2</li><li>Reduced activity of natural anticoagulants (Protein C &amp; Protein S)</li><li>Increased prothrombin activation</li></ul></li></ul></li><li><strong>Clinical Features:</strong><ul><li><strong>Thrombotic Events:</strong><ul><li>Venous thrombosis (e.g., deep vein thrombosis)</li><li>Arterial thrombosis (e.g., stroke, myocardial infarction)</li></ul></li><li><strong>Hematological Involvement:</strong><ul><li>Autoimmune hemolytic anemia</li><li>Thrombocytopenia</li></ul></li><li><strong>Renal Complications:</strong><ul><li>Renal artery or vein thrombosis</li><li>Glomerular thrombosis</li></ul></li><li><strong>Pregnancy-related Complications:</strong><ul><li>Recurrent miscarriages</li><li>Preterm birth</li><li>Fetal growth restriction (FGR)</li><li>Preeclampsia and HELLP syndrome</li><li>Intrauterine fetal death</li></ul></li></ul></li></ul><ul><li><strong>Management:</strong></li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/19E.png\"><p><strong>Explanation of other options:</strong></p><p><strong>Aspirin only (Option A): </strong>Aspirin alone reduces platelet aggregation but does not adequately prevent the thrombotic events associated with antiphospholipid syndrome in pregnancy.</p><p><strong>Heparin + steroids (Option C): </strong>Steroids are not routinely recommended for APS in pregnancy and are reserved for refractory cases or specific autoimmune conditions.</p><p><strong>Aspirin + Steroids (Option D): </strong>Corticosteroids are not considered standard therapy for APS in pregnancy, and their use may increase maternal and fetal risks without clear benefit in this setting.</p><p><strong>Reference: </strong><a href=\"https://sso.uptodate.com/contents/antiphospholipid-syndrome-obstetric-implications-and-management-in-pregnancy?search=APLA&amp;source=search_result&amp;selectedTitle=7~150&amp;usage_type=default&amp;display_rank=6\">https://sso.uptodate.com/contents/antiphospholipid-syndrome-obstetric-implications-and-management-in-pregnancy?search=APLA&amp;source=search_result&amp;selectedTitle=7~150&amp;usage_type=default&amp;display_rank=6</a></p>",
      "correct_choice_id": 182,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometriosis</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenomyosis</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Leiomyoma</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrial hyperplasia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old woman presents with lower abdominal discomfort and a mass. On pelvic examination, the uterus is uniformly enlarged, and the adnexa are free. MRI reveals the presence of a cyst within the myometrium. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q289437",
      "question_audio": null,
      "question_video": null,
      "map_id": 289437,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The clinical features of lower abdominal discomfort and mass, along with a uniformly enlarged uterus and myometrial cyst on MRI, point towards the diagnosis of <strong>adenomyosis</strong>, where endometrial tissue infiltrates the myometrium.</p><p><strong>Adenomyosis:</strong></p><ul><li>Characterized by the presence of endometrial glands and stroma within the myometrium, leading to uniform enlargement of the uterus.</li><li><strong>Types:</strong><ul><li><strong>Diffuse Adenomyosis:</strong> Scattered endometrial tissue throughout the myometrium.</li><li><strong>Focal Adenomyosis:</strong> Localized nodular collection of endometrial tissue.</li></ul></li><li><strong>Gross Features:</strong><ul><li>Uterus enlarged, typically <strong>not exceeding 12 weeks in size</strong>.</li><li>Outer surface appears <strong>smooth, regular, reddish, and soft</strong>.</li><li>Cut surface shows a <strong>spongy or trabeculated appearance</strong>, with areas of hemorrhage.</li></ul></li><li><strong>Pathophysiology:</strong><ul><li>Thought to result from the <strong>downward growth of the endometrial basalis layer</strong> into the myometrium.</li></ul></li><li><strong>Risk Factors:</strong><ul><li>Age <strong>over 40 years</strong>.</li><li>History of <strong>uterine surgeries</strong>.</li><li>Influence of <strong>estrogen and progesterone</strong>.</li></ul></li><li><strong>Clinical Features:</strong><ul><li><strong>Heavy menstrual bleeding</strong> (menorrhagia).</li><li><strong>Painful menstruation</strong> (dysmenorrhea).</li><li><strong>Painful intercourse</strong> (dyspareunia) in some cases.</li><li><strong>Pelvic discomfort</strong> and <strong>backache</strong>.</li></ul></li><li><strong>Radiological Findings:</strong><ul><li><strong>Ultrasound (USG):</strong><ul><li>Investigation of choice, though less sensitive than MRI.</li><li><strong>Shutter/Venetian Blind sign:</strong> Echogenic linear striations suggest endometrial invasion.</li><li><strong>Colour Doppler:</strong> Shows central vascularity (leiomyomas show peripheral vascularity).</li></ul></li></ul></li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/20E.png\"><ul><li><strong>MRI:</strong><ul><li><strong>Increased thickness</strong> of the junctional zone (&gt;12 mm).</li><li>Presence of <strong>myometrial cysts</strong> is suggestive.</li><li>High-intensity foci in the myometrium on <strong>T2-weighted images</strong>.</li><li><strong>Gadolinium contrast</strong> does not improve diagnostic accuracy.</li></ul></li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/20E1.png\"><p><strong>Explanation of other options:</strong></p><p><strong>Endometriosis (Option A): </strong>Endometrial tissue grows outside the uterus (e.g., ovaries, peritoneum), and does not present with a uniformly enlarged uterus or myometrial cysts on MRI.</p><p><strong>Leiomyoma (Option C): </strong>These are well-defined solid masses (fibroids) in the uterus, not cystic, and the uterus may be irregularly enlarged rather than uniformly enlarged.</p><p><strong>Endometrial hyperplasia (Option D): </strong>This condition leads to thickening of the endometrium and abnormal bleeding but does not cause uterine enlargement or cysts within the myometrium.</p>",
      "correct_choice_id": 192,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Ask the patient to pass urine</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Check for discomfort</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Ask the patient to perform a Valsalva maneuver</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Admit two fingers between the pessary and vaginal wall</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old woman has been fitted with a vaginal pessary for pelvic organ prolapse. What is the first step to confirm adequate pessary retention?</span></p>",
      "unique_key": "Q289438",
      "question_audio": null,
      "question_video": null,
      "map_id": 289438,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>Asking the patient to perform the <strong>Valsalva maneuver</strong> or <strong>cough </strong>helps assess whether the pessary stays in place during straining, confirming proper retention.</p><p><strong>Vaginal Pessary:</strong></p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/21E.png\"><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/21E1.png\"><p><strong>Assessing Pessary Retention:</strong></p><ul><li>A <strong>small gap (one finger)</strong> should be present between the pessary edge and vaginal wall</li><li>The pessary should not descend beyond the introitus</li><li>During <strong>Valsalva maneuver or coughing</strong>, slight descent may occur, but the pessary should return to its original position</li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Ask the patient to pass urine (Option A)</strong>: Passing urine checks for comfort but does not directly assess pessary retention. The pessary could still be displaced even if the patient voids normally.</p><p><strong>Check for discomfort (Option B)</strong>: Discomfort suggests a poor fit rather than good retention. A well-fitted pessary should be comfortable and retained, so discomfort alone is not a reliable indicator.</p><p><strong>Admit two fingers between the pessary and vaginal wall (Option D)</strong>: If two fingers can be placed between the pessary and vaginal wall, it means the pessary is too loose and not properly retained. Only one finger space is considered normal for a good fit.</p>",
      "correct_choice_id": 203,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Placenta accreta syndrome</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Uterine inversion</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Abruptio placenta</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Placenta previa</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A G2P1L1 woman with a previous history of lower segment cesarean section (LSCS) presents to the emergency department with antepartum hemorrhage. During surgical management, an obstetric hysterectomy was performed. The specimen obtained during surgery is shown below. Based on the clinical scenario and specimen appearance, what is the most likely diagnosis?<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/22Q.png\"></span></p>",
      "unique_key": "Q289439",
      "question_audio": null,
      "question_video": null,
      "map_id": 289439,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The woman with a history of LSCS presenting with antepartum hemorrhage and requiring hysterectomy likely had <strong>placenta accreta spectrum</strong>, where the placenta abnormally adheres to the uterine wall, preventing normal separation after delivery.</p><p><strong>Placenta Accreta Syndrome:</strong></p><ul><li>Abnormal adherence of the placenta to the uterine wall, preventing its natural separation after childbirth.</li><li><strong>Cause:</strong><ul><li>Defective formation of the <strong>decidua basalis</strong>.</li><li>Incomplete development of the <strong>fibrinoid (Nitabuch) layer</strong>.</li></ul></li><li><strong>Pathophysiology:</strong><ul><li>Abnormal invasion of <strong>trophoblastic tissue</strong> into the uterine wall.</li><li>Hinders normal placental separation after delivery.</li></ul></li><li><strong>Clinical Diagnosis:</strong><ul><li>Suspected when manual removal of the placenta fails.</li><li>No clear plane of separation between the placenta and the uterine wall.</li></ul></li><li><strong>Complications:</strong><ul><li>Severe <strong>postpartum hemorrhage (PPH)</strong>.</li><li><strong>Infection</strong>.</li><li>Risk of <strong>uterine inversion</strong>.</li></ul></li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/22E.png\"><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/22E1.png\"><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/22E2.png\"><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/22E3.png\"><p><strong>Explanation of other options:</strong></p><p><strong>Uterine inversion (Option B):</strong> Uterine inversion occurs when the uterus turns inside-out, usually immediately after delivery due to excessive cord traction; it does not explain the need for a hysterectomy during surgery for placenta-related bleeding as seen in this case.</p><p><strong>Abruptio placenta (Option C): </strong>Placental abruption involves premature separation of the placenta before delivery, presenting with painful bleeding, but it does not lead to adherent placenta or require a hysterectomy for removal of placental tissue.</p><p><strong>Placenta previa (Option D):</strong> Placenta previa is when the placenta covers the cervical opening, causing painless antepartum bleeding, but it is usually managed based on ultrasound findings and rarely requires hysterectomy unless complicated by abnormal placental adherence like accreta.</p>",
      "correct_choice_id": 211,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory rate (RR) < 18 breaths per minute</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Visual disturbances start</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Knee-jerk reflex is present</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Urine output of less than 120 ml in 4 hours</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant woman at 32 weeks' gestation presents with a blood pressure of 160/110 mmHg and a heart rate of 120 bpm. On examination, she has pedal edema, and laboratory tests reveal significant proteinuria. She is diagnosed with eclampsia and started on magnesium sulfate following the Pritchard protocol. Under which of the following circumstances should magnesium sulfate administration be reconsidered or withheld?</span></p>",
      "unique_key": "Q289440",
      "question_audio": null,
      "question_video": null,
      "map_id": 289440,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>Magnesium sulfate</strong> is withheld if urine output is<strong> &lt;30 mL/hour (120 mL/4 hours) </strong>due to risk of toxicity from impaired renal clearance.</p><p><strong>Magnesium Sulfate in Eclampsia:</strong></p><ul><li><strong>Preferred drug</strong> for preventing seizures in pregnant women with <strong>severe preeclampsia or eclampsia.</strong></li><li><strong>Pritchard Regimen:</strong><ul><li><strong>Loading Dose:</strong><ul><li>4 g IV (20 mL of 20% Mg<sub>4</sub> solution) over 3-5 minutes.</li><li>Followed by 10 g IM (50% solution), 5 g in each buttock.</li></ul></li><li><strong>Maintenance Dose:</strong><ul><li>5 g IM (50% solution) every 4 hours in alternate buttocks.</li><li>Continue for 24 hours after delivery or the last convulsion.</li></ul></li></ul></li><li><strong>Pre-administration Checks:</strong><ul><li><strong>Respiratory rate</strong> at least <strong>16/min</strong>.</li><li><strong>Patellar (knee jerk) reflex</strong> should be present.</li><li><strong>Urine output</strong> should be at least <strong>30 mL/hour</strong> (i.e., 120 mL over 4 hours).</li></ul></li><li><strong>Signs of Magnesium Toxicity:</strong><ul><li>Loss of deep tendon reflexes.</li><li>Respiratory rate &lt; 12/min.</li><li>Absent patellar reflexes.</li><li>Urine output &lt; 30 mL/hour.</li></ul></li><li><strong>Management of Magnesium Toxicity:</strong><ul><li><strong>Immediate Actions:</strong><ul><li>Administer <strong>10 mL of 10% calcium gluconate</strong> IV over 3 minutes (antidote).</li><li>Stop magnesium sulfate administration.</li></ul></li><li><strong>Further Management:</strong><ul><li>Give <strong>furosemide</strong> to promote urinary excretion of magnesium.</li><li>In severe cases, provide <strong>intubation and mechanical ventilation</strong>.</li></ul></li></ul></li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Respiratory rate (RR) &lt; 18 breaths per minute (Option A): </strong>A respiratory rate below 18 is slightly concerning, but magnesium sulfate is only withheld if the rate drops below 12 breaths per minute, which indicates significant respiratory depression.</p><p><strong>Visual disturbances start (Option B):</strong> Visual disturbances are a feature of worsening preeclampsia or impending eclampsia, not a sign of magnesium toxicity, so they are not a reason to stop magnesium sulfate.</p><p><strong>Knee-jerk reflex is present (Option C):</strong> The presence of a patellar (knee-jerk) reflex is reassuring, indicating magnesium levels are within a safe range; it is the absence of this reflex that suggests toxicity.</p><p><strong>Reference:&nbsp;</strong><a href=\"https://www.bioline.org.br/pdf?am09018\">https://www.bioline.org.br/pdf?am09018</a>, Page 78</p>",
      "correct_choice_id": 224,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Chlamydial infection</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Bartholin's abscess</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Genital tuberculosis</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Herpes infection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman presents with pain and swelling in the perianal area, along with difficulty walking and sitting. On examination, a tender, red swelling is seen on the labia, as illustrated in the provided image. What is the most likely diagnosis?<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/24Q.png\"></span></p>",
      "unique_key": "Q289441",
      "question_audio": null,
      "question_video": null,
      "map_id": 289441,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The symptoms of <strong>severe pain, swelling, redness, and a tender mass on the labia</strong> strongly suggest a <strong>Bartholin's abscess</strong>. This occurs due to blockage and subsequent infection of the Bartholin gland, leading to abscess formation.</p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/24E.png\"><p><strong>Bartholin Cyst and Abscess:</strong></p><ul><li><strong>Bartholin Cyst Characteristics:</strong><ul><li>Painless, smooth, cystic swelling.</li><li>Typically located in the <strong>inferior part of the labia majora</strong> or <strong>posterior vestibule near the fourchette</strong>.</li></ul></li><li><strong>Bartholin Gland Characteristics:</strong><ul><li>Normally <strong>bilateral</strong> and measure around <strong>0.5 to 1 cm</strong> in diameter.</li><li>Located <strong>deep in the vestibular bulb</strong> and the <strong>bulbospongiosus muscle</strong>.</li></ul></li><li><strong>Complication:</strong><ul><li>Blockage of the duct may lead to <strong>infection</strong> and <strong>abscess formation</strong>.</li></ul></li><li><strong>Common Causative Organisms:</strong><ul><li>E. coli</li><li>Gram-positive and gram-negative aerobes</li><li>Anaerobic bacteria</li></ul></li><li><strong>Clinical Features of Bartholin Abscess:</strong><ul><li>Severe <strong>vulvar pain</strong>, especially during walking, sitting, or intercourse.</li><li>Swelling in the labial region.</li><li><strong>Redness (erythema)</strong> and tenderness over the swelling.</li><li><strong>Tender mass</strong> felt on the labia.</li><li><strong>Labial asymmetry</strong> may be seen if the abscess is large.</li></ul></li><li><strong>Treatment:</strong><ul><li><strong>Incision and drainage (I&amp;D)</strong> for abscesses.</li><li><strong>Marsupialisation</strong> to prevent recurrence.</li><li><strong>Excision of the Bartholin gland</strong> in recurrent or complicated cases.</li></ul></li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Chlamydial infection</strong> <strong>(Option A):</strong> Usually presents with vaginal discharge, dysuria, or pelvic pain; it does not cause a localized tender swelling on the labia like a Bartholin abscess.</p><p><strong>Genital tuberculosis</strong> <strong>(Option C): </strong>Typically associated with chronic pelvic pain, menstrual irregularities, or infertility; it rarely presents as an acute, red, tender labial swelling.</p><p><strong>Herpes infection</strong> <strong>(Option D):</strong> Causes painful vesicles or ulcers, not a firm, tender, fluctuant mass as seen with a Bartholin abscess.</p>",
      "correct_choice_id": 232,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">HELLP syndrome</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute fatty liver of pregnancy</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Viral hepatitis</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Intrahepatic cholestasis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 34-week pregnant woman presents to the outpatient department with laboratory investigations showing LDH of 700 IU/L, platelet count of 75,000/mm<sup>3</sup>, serum bilirubin of 1.5 mg/dL, SGOT of 200 U/L, SGPT of 150 U/L, and blood pressure of 140/96 mmHg. Her coagulation profile and renal function tests are within normal limits. Based on these findings, what is the most likely diagnosis?</span></p>",
      "unique_key": "Q289442",
      "question_audio": null,
      "question_video": null,
      "map_id": 289442,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The patient has <strong>elevated LDH, low platelets, and raised liver enzymes</strong>, along with <strong>hypertension</strong>, all pointing towards <strong>HELLP syndrome</strong>, a severe complication of preeclampsia.</p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/25E.png\"><p><strong>Explanation of other options:</strong></p><p><strong>Acute fatty liver of pregnancy (Option B): </strong>Typically presents with severe liver dysfunction, hypoglycemia, and coagulopathy, but usually does not cause significant hypertension or such low platelet counts as seen in this patient.</p><p><strong>Viral hepatitis (Option C):</strong> Markedly higher transaminase levels (often &gt;2000 U/L) are expected, with no associated thrombocytopenia or hypertension, which are present in this case.</p><p><strong>Intrahepatic cholestasis (Option D): </strong>Primarily presents with intense pruritus and mildly raised liver enzymes and bilirubin, but platelet counts and blood pressure usually remain normal.</p><p><strong>Reference: </strong><a href=\"https://my.clevelandclinic.org/health/diseases/21637-hellp-syndrome\">https://my.clevelandclinic.org/health/diseases/21637-hellp-syndrome</a></p>",
      "correct_choice_id": 241,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">Vacuum</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">Outlet forceps</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">Low cavity forceps</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">Wait and observe</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A primigravida at 40 weeks of pregnancy presents in active labour. She has entered the second stage, with the fetal head at +3 station and caput +1. What is the most appropriate next step in management?</span></p>",
      "unique_key": "Q289443",
      "question_audio": null,
      "question_video": null,
      "map_id": 289443,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The fetal head at +3 station with caput formation indicates that the head is low and visible at the perineum, making <strong>outlet forceps</strong> the most appropriate method to assist delivery in this case.</p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/26E.png\"><p><strong>Explanation of other options:</strong></p><p><strong>Vacuum (Option A): </strong>Vacuum extraction is more appropriate when the fetal head is at a slightly higher station (typically +2 or lower) and is not the first choice when the head is already at +3 station and visible at the perineum.</p><p><strong>Low cavity forceps (Option C):</strong> These are used when the head is engaged but still higher in the birth canal (+2 station or lower), making them unsuitable when the fetal head is already at +3 station.</p><p><strong>Wait and observe (Option D):</strong> While observation is acceptable in the early second stage, at the +3 station with caput formation, timely intervention with outlet forceps helps avoid complications like fetal distress or prolonged labour.</p>",
      "correct_choice_id": 252,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 27,
      "choices": [
        {
          "id": 261,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in systolic and diastolic blood pressure after 6 weeks</span></p>"
        },
        {
          "id": 262,
          "text": "<p><span style=\"font-size:12.0pt;\">Peripheral resistance to insulin leading to hyperinsulinemia</span></p>"
        },
        {
          "id": 263,
          "text": "<p><span style=\"font-size:12.0pt;\">Fasting hypoglycemia and postprandial hyperglycemia</span></p>"
        },
        {
          "id": 264,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased plasma volume and RBC mass</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not considered a normal physiological change during pregnancy?</span></p>",
      "unique_key": "Q289444",
      "question_audio": null,
      "question_video": null,
      "map_id": 289444,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>An <strong>increase in systolic and diastolic blood pressure after 6 weeks</strong> is not a normal physiological change in pregnancy, as blood pressure typically <strong>decreases in early pregnancy</strong> and reaches its lowest point by 24-26 weeks.<strong><br /> </strong></p><p><strong>Blood Pressure in Pregnancy:</strong></p><ul><li>Blood pressure decreases during early pregnancy, reaching its lowest point around <strong>24 to 26 weeks</strong>. <strong>(Option A)</strong></li><li>The <strong>diastolic pressure</strong> typically falls more than the systolic pressure.</li><li><strong>Positional influence</strong>: Blood pressure is lower when lying on the side compared to sitting or lying flat (supine).</li><li><strong>Supine Hypotensive Syndrome</strong>: The enlarged uterus can compress major blood vessels when lying flat, leading to significant hypotension in some women.</li></ul><p><strong>Blood Volume in Pregnancy:</strong></p><ul><li><strong>Total blood volume</strong> increases by about <strong>40-45%</strong> by <strong>32-34 weeks</strong> of gestation, with near doubling in some women.</li><li><strong>Plasma volume</strong> increases more than red blood cell mass. <strong>(Option D)</strong></li><li><strong>Erythrocyte volume</strong> rises by approximately <strong>450 mL</strong> due to enhanced bone marrow activity and increased erythropoietin levels.</li><li><strong>Hemoglobin concentration</strong> decreases slightly, averaging around <strong>5 g/dL</strong> at term.</li></ul><p><strong>Metabolic Changes in Pregnancy:</strong></p><ul><li>Pregnancy is associated with <strong>mild fasting hypoglycemia</strong>, <strong>postprandial hyperglycemia</strong>, and <strong>hyperinsulinemia</strong>. <strong>(Option B)</strong></li><li><strong>Insulin resistance</strong> increases by <strong>30-70%</strong> during late pregnancy.</li><li>This resistance is caused by:<ul><li><strong>Hormones</strong> such as progesterone, cortisol, placental growth hormone, and prolactin.</li><li><strong>Cytokines,</strong> including tumor necrosis factor and leptin.</li></ul></li><li><strong>Post-meal glucose levels</strong> are elevated due to insulin resistance and increased liver glucose production.</li><li><strong>During fasting: (Option C)</strong><ul><li><strong>Blood glucose</strong> and amino acid levels <strong>decrease.</strong></li><li>Free fatty acids, triglycerides, and cholesterol levels rise.</li><li>The body shifts towards <strong>ketone production</strong>, especially with prolonged fasting.</li></ul></li></ul>",
      "correct_choice_id": 261,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 28,
      "choices": [
        {
          "id": 271,
          "text": "<p><span style=\"font-size:12.0pt;\">Dimeric inhibin B</span></p>"
        },
        {
          "id": 272,
          "text": "<p><span style=\"font-size:12.0pt;\">Unconjugated estradiol</span></p>"
        },
        {
          "id": 273,
          "text": "<p><span style=\"font-size:12.0pt;\">AFP</span></p>"
        },
        {
          "id": 274,
          "text": "<p><span style=\"font-size:12.0pt;\">&beta;-hCG</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old pregnant woman, G2P1L1, undergoes a second-trimester screening test known as the quadruple test at 16 weeks of gestation. Which of the following is not a component of this test?</span></p>",
      "unique_key": "Q289445",
      "question_audio": null,
      "question_video": null,
      "map_id": 289445,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>Dimeric inhibin B</strong> is not part of the <strong>quadruple test</strong>, which includes AFP, &beta;-hCG, unconjugated estriol, and inhibin A.</p><p><strong>Quadruple Test:</strong></p><ul><li>A prenatal screening is performed between <strong>15 to 21 weeks of pregnancy</strong>.</li><li>Primarily used to assess the risk of <strong>chromosomal abnormalities</strong>, particularly <strong>Down syndrome (Trisomy 21)</strong>.</li><li><strong>Markers Tested:</strong><ul><li><strong>MSAFP</strong> (Maternal Serum Alpha-Fetoprotein) <strong>(Option C)</strong></li><li><strong>hCG</strong> (Human Chorionic Gonadotropin) <strong>(Option D)</strong></li><li><strong>Unconjugated Estriol (Option B)</strong></li><li><strong>Dimeric Inhibin A</strong></li></ul></li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/28E.png\"><p><strong>Note:</strong> Inhibin A is not taken into account for Edward&rsquo;s Syndrome.</p><ul><li>The Quadruple Test is often combined with first-trimester screening for improved detection rates.</li></ul><p><strong>Reference: </strong><a href=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC4161588/\">https://pmc.ncbi.nlm.nih.gov/articles/PMC4161588/#</a></p>",
      "correct_choice_id": 271,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29,
      "choices": [
        {
          "id": 281,
          "text": "<p><span style=\"font-size:12.0pt;\">Candida</span></p>"
        },
        {
          "id": 282,
          "text": "<p><span style=\"font-size:12.0pt;\">Trichomonas vaginalis</span></p>"
        },
        {
          "id": 283,
          "text": "<p><span style=\"font-size:12.0pt;\">Bacterial vaginosis</span></p>"
        },
        {
          "id": 284,
          "text": "<p><span style=\"font-size:12.0pt;\">Physiological cause</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 24-year-old woman presents with complaints of foul-smelling vaginal discharge. A wet mount examination of the discharge is shown below. Based on the findings, what is the most likely diagnosis?<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/29Q.png\"></span></p>",
      "unique_key": "Q289446",
      "question_audio": null,
      "question_video": null,
      "map_id": 289446,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The presence of foul-smelling vaginal discharge, along with <strong>clue cells</strong> on microscopy, strongly suggests <strong>bacterial vaginosis</strong>.</p><p><strong>Bacterial Vaginosis (BV):</strong></p><ul><li>Polymicrobial condition with disruption of normal vaginal flora</li><li>Involves reduced <strong>lactobacilli</strong> and overgrowth of <strong>anaerobic bacteria</strong></li><li><strong>Minimal inflammation</strong>, few leukocytes seen in vaginal fluid</li><li><strong>Not considered a sexually transmitted infection</strong></li><li><strong>Causative Organism:</strong> Gardnerella vaginalis</li><li><strong>Clinical Features:</strong><ul><li>50% of cases are <strong>asymptomatic</strong></li><li>Vaginal discharge: <strong>white, thin, non-viscous</strong>, adheres to vaginal walls</li><li><strong>Mild vulval irritation</strong> may be present</li></ul></li><li><strong>Diagnostic Criteria (Amsel's Criteria):</strong><ul><li>Thin, white, homogeneous discharge adherent to vaginal walls</li><li>Vaginal pH <strong>greater than 4.5</strong></li><li><strong>Fishy odor</strong> on adding 10% KOH (positive whiff test)</li><li><strong>Clue cells</strong> are seen on microscopic examination<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/29E.png\"></li></ul></li><li><strong>Complications:</strong><ul><li>Pelvic Inflammatory Disease (<strong>PID</strong>)</li><li><strong>Chorioamnionitis</strong></li><li>Premature Rupture of Membranes (<strong>PROM</strong>)</li><li><strong>Preterm labor</strong></li></ul></li><li><strong>Treatment:</strong><ul><li><strong>First-line (DOC): Metronidazole</strong><ul><li>400 mg orally, twice daily for 7 days (<strong>85% effective</strong>)</li><li>Single 1 g dose is less effective</li></ul></li><li><strong>Alternative:</strong> Clindamycin<ul><li>2% vaginal cream</li><li>Oral 300 mg daily for 7 days</li></ul></li></ul></li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Candida</strong> <strong>(Option A): </strong>Typically presents with thick, curd-like, white discharge and intense itching, not with foul-smelling discharge; microscopy shows pseudohyphae and yeast, not clue cells.</p><p><strong>Trichomonas vaginalis (Option B):</strong> Causes frothy, yellow-green discharge with itching and dysuria, and wet mount shows motile trichomonads, not clue cells; fishy odor is less prominent.</p><p><strong>Physiological cause (Option D):</strong> Normal discharge is clear, non-offensive, and odorless, varies with the menstrual cycle, and does not show abnormal findings on microscopy.</p>",
      "correct_choice_id": 283,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30,
      "choices": [
        {
          "id": 291,
          "text": "<p><span style=\"font-size:12.0pt;\">Advise her to wait for the next menstrual cycle to take DMPA</span></p>"
        },
        {
          "id": 292,
          "text": "<p><span style=\"font-size:12.0pt;\">Give DMPA now and recommend backup contraception for 7 days</span></p>"
        },
        {
          "id": 293,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer DMPA now; backup contraception is not required</span></p>"
        },
        {
          "id": 294,
          "text": "<p><span style=\"font-size:12.0pt;\">Perform a urine pregnancy test before giving DMPA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old nulligravida who is using Depot Medroxyprogesterone Acetate (DMPA) for contraception presents 14 days after her scheduled date for the next DMPA injection. What is the next best step?</span></p>",
      "unique_key": "Q289447",
      "question_audio": null,
      "question_video": null,
      "map_id": 289447,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>DMPA is an injectable contraceptive given <strong>every 3 months (90 days)</strong>. There is a <strong>grace period of up to 4 weeks</strong> after the due date during which the next dose can be administered without needing backup contraception. Since the woman is only <strong>14 days late</strong>, DMPA can be given immediately, and additional contraception is not necessary.</p><p><strong>Depot Medroxyprogesterone Acetate (DMPA):</strong></p><ul><li><strong>Dosage &amp; Route:</strong><ul><li>150 mg <strong>intramuscular injection</strong> every <strong>90 days</strong>.</li></ul></li><li><strong>Mechanism of Action:</strong><ul><li>Suppresses <strong>ovulation</strong>.</li><li>Increases cervical mucus viscosity, hindering <strong>sperm penetration</strong>.</li><li>Alters the endometrial lining to prevent <strong>implantation</strong>.</li></ul></li><li><strong>Benefits/Effects:</strong><ul><li><strong>Does not interfere</strong> with breastfeeding.</li><li>Lowers the risk of <strong>iron deficiency anaemia</strong>, <strong>sickle cell crises</strong>, and <strong>endometriosis</strong>.</li><li>Return to fertility may be <strong>delayed by 6 to 12 months</strong> after stopping.</li></ul></li><li><strong>Side Effects:</strong><ul><li>Decreased <strong>bone mineral density</strong>.</li><li><strong>Mood disturbances</strong>, such as depression.</li><li><strong>Weight gain</strong>.</li><li><strong>Headaches</strong>.</li></ul></li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/30E.png\"><p><strong>Explanation of other options:</strong></p><p><strong>Advise her to wait for the next menstrual cycle to take DMPA</strong> <strong>(Option A): </strong>This is incorrect because waiting for the next cycle is unnecessary; DMPA can be safely given if the woman is within 4 weeks of the scheduled dose, as in this case.</p><p><strong>Give DMPA now and recommend backup contraception for 7 days (Option B): </strong>Backup contraception is recommended only if the woman is more than 4 weeks late for the injection; here, she is only 2 weeks late, so backup is not required.</p><p><strong>Perform a urine pregnancy test before giving DMPA (Option D): </strong>A pregnancy test is advised only if the delay exceeds 4 weeks or pregnancy is suspected; this woman is still within the grace period, so UPT is not mandatory.</p>",
      "correct_choice_id": 293,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31,
      "choices": [
        {
          "id": 301,
          "text": "<p><span style=\"font-size:12.0pt;\">3,1,2,4</span></p>"
        },
        {
          "id": 302,
          "text": "<p><span style=\"font-size:12.0pt;\">3,2,4,1</span></p>"
        },
        {
          "id": 303,
          "text": "<p><span style=\"font-size:12.0pt;\">2,4,3,1</span></p>"
        },
        {
          "id": 304,
          "text": "<p><span style=\"font-size:12.0pt;\">2,4,1,3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26-year-old primigravida delivers a healthy newborn via normal vaginal delivery at a primary healthcare center. The healthcare provider initiates Active Management of the Third Stage of Labor (AMTSL) to prevent postpartum hemorrhage.<br><br>The following actions are considered:<br>1. Uterine massage<br>2. Administration of uterotonic (Oxytocin 10 IU)<br>3. Ruling out the presence of another fetus<br>4. Controlled cord traction<br><br>What is the correct sequence of these steps during AMTSL?</span></p>",
      "unique_key": "Q289448",
      "question_audio": null,
      "question_video": null,
      "map_id": 289448,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The correct sequence in Active Management of the Third Stage of Labor (AMTSL) is <strong>3, 2, 4, 1.</strong></p><p><strong>Steps Before Starting AMTSL (Active Management of the Third Stage of Labor):</strong></p><ul><li>Confirm that the baby has been delivered.</li><li><strong>Exclude the presence of another fetus</strong> in the uterus. <strong>(Statement 3)</strong></li><li>Assess fetal condition, position, and lie.</li><li>Prepare the uterotonic drug (e.g., oxytocin).</li><li>Check maternal vital signs and overall condition.</li><li>Keep instruments for cord clamping ready.</li><li>Inform the mother about the procedure.</li><li>Check for clinical signs of placental separation.</li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/31E.png\"><p><strong>Reference: </strong><a href=\"http://apps.who.int/iris/bitstream/handle/10665/119831/WHO_RHR_14.18_eng.pdf.jsessionid=FE3D2474A97F98A7F42B321A1DBAC020?sequence=1\">WHO Active Management of the Third Stage of Labor</a>.</p>",
      "correct_choice_id": 302,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32,
      "choices": [
        {
          "id": 311,
          "text": "<p><span style=\"font-size:12.0pt;\">Anencephaly</span></p>"
        },
        {
          "id": 312,
          "text": "<p><span style=\"font-size:12.0pt;\">Omphalocele</span></p>"
        },
        {
          "id": 313,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystic hygroma</span></p>"
        },
        {
          "id": 314,
          "text": "<p><span style=\"font-size:12.0pt;\">Encephalocele</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 31-year-old pregnant woman at 20 weeks' gestation presents for a second opinion after being told that her fetus has a developmental defect. The ultrasound shows the absence of cranial bones and exposed brain tissue. What is the most likely diagnosis?<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/32Q.png\"></span></p>",
      "unique_key": "Q289449",
      "question_audio": null,
      "question_video": null,
      "map_id": 289449,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The absence of cranial bones with exposed brain tissue on ultrasound points towards a diagnosis of<strong> anencephaly.</strong></p><p><strong>Anencephaly:</strong></p><ul><li>Absence of the <strong>cranium</strong> and <strong>telencephalon</strong> above the skull base and orbits.</li><li><strong>Developmental Sequence:</strong><ul><li>Begins as <strong>acrania</strong> (absence of cranial bones with abnormal brain tissue).</li><li>Progresses to <strong>exencephaly</strong> (herniated, exposed brain tissue).</li><li>Final stage is <strong>anencephaly</strong>, where most of the brain and skull are absent.</li></ul></li><li><strong>Cause:</strong><ul><li>Results from the <strong>failure of neural tube closure</strong> during early embryonic development.</li></ul></li><li><strong>Detection:</strong><ul><li>It can be identified as early as <strong>10-11 weeks</strong> of gestation.</li><li>Detected through <strong>ultrasound</strong> or elevated <strong>maternal serum alpha-fetoprotein (MSAFP)</strong></li></ul></li><li><strong>Ultrasound Features:</strong><ul><li>Abnormal shape of the fetal head in the first trimester.</li><li>Absent <strong>ossification</strong> of the cranium.</li><li><strong>Shower cap sign:</strong> Disorganized brain tissue protrudes above the skull base.</li><li><strong>Frog eye sign:</strong> Prominent orbits are visible due to absent skull bones.<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/32E.png\"></li></ul></li><li><strong>Prognosis:</strong><ul><li>Anencephaly is <strong>lethal</strong>, with no chance of survival after birth.</li><li>Parents should be counseled regarding <strong>perinatal palliative care</strong> if pregnancy continues.</li></ul></li><li><strong>Prevention:</strong><ul><li><strong>Folic acid supplementation</strong> (4 mg daily) before conception significantly reduces the risk of neural tube defects.</li></ul></li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Omphalocele (Option B): </strong>This is a congenital abdominal wall defect where abdominal organs herniate into the base of the umbilical cord, covered by a membrane; it does not involve the skull or brain.</p><p><strong>Cystic hygroma (Option C): </strong>A lymphatic malformation presenting as a multiloculated cystic mass, usually in the posterior neck, unrelated to cranial or brain defects.</p><p><strong>Encephalocele (Option D):</strong> A neural tube defect where brain tissue herniates through a localized skull defect, but unlike anencephaly, the cranium is still partially present.</p>",
      "correct_choice_id": 311,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33,
      "choices": [
        {
          "id": 321,
          "text": "<p><span style=\"font-size:12.0pt;\">Blighted ovum</span></p>"
        },
        {
          "id": 322,
          "text": "<p><span style=\"font-size:12.0pt;\">Missed abortion</span></p>"
        },
        {
          "id": 323,
          "text": "<p><span style=\"font-size:12.0pt;\">Ectopic pregnancy</span></p>"
        },
        {
          "id": 324,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydatidiform mole</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 22-year-old primigravida at 10 weeks of pregnancy presents with complaints of vaginal spotting. On examination, the uterus appears larger than expected, corresponding to approximately 12 weeks' size. A transvaginal ultrasound is performed, as shown below. Based on the clinical findings and ultrasound image, what is the most likely diagnosis?<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/33Q.png\"></span></p>",
      "unique_key": "Q289450",
      "question_audio": null,
      "question_video": null,
      "map_id": 289450,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The clinical scenario of vaginal spotting with uterine size larger than dates, along with ultrasound showing a heterogeneous echogenic mass with multiple anechoic cystic spaces (<strong>snowstorm appearance</strong>), is characteristic of a <strong>hydatidiform mole</strong>.</p><p><strong>Hydatidiform Mole (Benign Gestational Trophoblastic Disease):</strong></p><ul><li>Abnormal proliferation of trophoblastic tissue with swollen, fluid-filled chorionic villi.</li><li>Results in significantly elevated <strong>&beta;-hCG</strong> levels, often exceeding <strong>100,000 mIU/mL</strong>.</li><li>Though benign initially, it may progress to <strong>persistent GTD</strong> or, rarely, malignancy.</li><li><strong>Clinical Features:</strong><ul><li><strong>Amenorrhea</strong></li><li><strong>Vaginal bleeding</strong> (most common symptom)</li><li>Uterus larger than gestational age, soft in consistency</li><li><strong>Absent fetal heart sounds</strong> (especially in complete moles)</li><li><strong>Theca-lutein cysts</strong> in ovaries (&gt;6 cm in size)</li><li>Symptoms of <strong>hyperthyroidism</strong></li><li><strong>Severe preeclampsia/eclampsia</strong> (may occur early)</li><li>Lower abdominal discomfort</li><li><strong>Excessive nausea and vomiting</strong> (Hyperemesis gravidarum)</li></ul></li><li><strong>Diagnosis:</strong><ul><li><strong>&beta;-hCG levels:</strong> Markedly raised (&gt;100,000 mIU/mL)</li><li><strong>Ultrasound findings:</strong><ul><li>Echogenic intrauterine mass with multiple cystic spaces</li><li>Classic <strong>\"snowstorm appearance\"</strong></li><li>No identifiable fetus or amniotic sac (complete mole)<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/33E.png\"></li></ul></li></ul></li><li><strong>Management:</strong><ul><li><strong>Suction evacuation</strong> after cervical preparation</li><li><strong>Serial &beta;-hCG monitoring</strong> to ensure complete resolution</li><li><strong>Prophylactic chemotherapy</strong> (e.g., Methotrexate) for high-risk women (WHO score &gt;7)</li><li><strong>Contraception is advised for at least 1 year</strong> to avoid confusion with hCG monitoring</li></ul></li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Blighted ovum (Option A): </strong>Typically presents with an empty gestational sac without fetal parts, but there is no cystic \"snowstorm\" appearance, and the uterus is usually not larger than dates.</p><p><strong>Missed abortion (Option B): </strong>Characterized by fetal demise without expulsion, but ultrasound shows either a non-viable fetus or an empty sac, not multiple cystic spaces or snowstorm appearance.</p><p><strong>Ectopic pregnancy (Option C): </strong>The pregnancy implants outside the uterus, and ultrasound shows no intrauterine gestational sac, not a large uterus with cystic spaces as seen here.</p>",
      "correct_choice_id": 324,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34,
      "choices": [
        {
          "id": 331,
          "text": "<p><span style=\"font-size:12.0pt;\">8</span></p>"
        },
        {
          "id": 332,
          "text": "<p><span style=\"font-size:12.0pt;\">5</span></p>"
        },
        {
          "id": 333,
          "text": "<p><span style=\"font-size:12.0pt;\">3</span></p>"
        },
        {
          "id": 334,
          "text": "<p><span style=\"font-size:12.0pt;\">7</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A primigravida in active labor undergoes a vaginal examination. Findings reveal a posterior cervix, cervical length of 5 cm, 1 cm dilatation, soft consistency, and the fetal head at -1 station. Based on these findings, what is the modified Bishop score?</span></p>",
      "unique_key": "Q289451",
      "question_audio": null,
      "question_video": null,
      "map_id": 289451,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The <strong>Modified Bishop Score</strong> is calculated as follows:</p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/34E1.png\"><p><strong>Total Score:</strong> 1 + 0 + 2 + 0 + 2 = <strong>5</strong></p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/34E2.png\"><p><strong>Total Score:</strong> Sum of points from all five categories to assess the readiness of the cervix for labour induction.</p><p><strong>Interpretation:</strong></p><ul><li><strong>&le;6: </strong>Unfavorable cervix; cervical ripening may be required before induction.</li><li><strong>&ge;9:</strong> Favourable cervix; high success rate for induction of labor.</li></ul>",
      "correct_choice_id": 332,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 35,
      "choices": [
        {
          "id": 341,
          "text": "<p><span style=\"font-size:12.0pt;\">Early deceleration</span></p>"
        },
        {
          "id": 342,
          "text": "<p><span style=\"font-size:12.0pt;\">Late deceleration</span></p>"
        },
        {
          "id": 343,
          "text": "<p><span style=\"font-size:12.0pt;\">Variable deceleration</span></p>"
        },
        {
          "id": 344,
          "text": "<p><span style=\"font-size:12.0pt;\">Sinusoidal pattern</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 29-year-old woman at 40 weeks of gestation is in active labor. She has a history of gestational hypertension. Continuous CTG monitoring is being done, and the tracing is shown below. Based on the CTG, what is the most likely interpretation?<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/35Q.png\"></span></p>",
      "unique_key": "Q289452",
      "question_audio": null,
      "question_video": null,
      "map_id": 289452,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The CTG shows a gradual fetal heart rate decline starting after the peak of contraction, indicating <strong>late deceleration</strong> due to <strong>uteroplacental insufficiency</strong>.</p><br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/35E1.png\"><p><strong>Explanation of other options:</strong></p><p><strong>Sinusoidal Pattern (Option D): </strong>A sinusoidal pattern on CTG is characterized by a smooth, wave-like, undulating baseline with absent variability or accelerations, which is not seen in this CTG showing late decelerations.</p><br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/35E2.png\">",
      "correct_choice_id": 342,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 36,
      "choices": [
        {
          "id": 351,
          "text": "<p><span style=\"font-size:12.0pt;\">Cleidotomy</span></p>"
        },
        {
          "id": 352,
          "text": "<p><span style=\"font-size:12.0pt;\">McRoberts maneuver</span></p>"
        },
        {
          "id": 353,
          "text": "<p><span style=\"font-size:12.0pt;\">C-section</span></p>"
        },
        {
          "id": 354,
          "text": "<p><span style=\"font-size:12.0pt;\">Lateral traction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old diabetic woman is in active labor. After the baby's head is delivered, there is difficulty in delivering the shoulders despite gentle traction for over a minute. What is the next best step in management?</span></p>",
      "unique_key": "Q289453",
      "question_audio": null,
      "question_video": null,
      "map_id": 289453,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The most appropriate initial step for suspected <strong>shoulder dystocia</strong> is the <strong>McRoberts maneuver</strong>, which widens the pelvic outlet by hyperflexing the maternal hips.</p><p><strong>Management of Shoulder Dystocia:</strong></p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/36E.png\"><p><strong>Explanation of other options:</strong></p><p><strong>Cleidotomy (Option A): </strong>This is a last-resort procedure involving intentional fracture of the fetal clavicle to reduce shoulder width, only done if all standard maneuvers fail.</p><p><strong>C-section (Option C):</strong> C-section cannot be performed at this stage because the fetal head is already delivered; C-section is done before delivery, not during shoulder dystocia after head delivery.</p><p><strong>Lateral traction (Option D):</strong> Applying lateral traction on the fetal head increases the risk of brachial plexus injury and is not recommended; controlled maneuvers like McRoberts are preferred first.</p>",
      "correct_choice_id": 352,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 37,
      "choices": [
        {
          "id": 361,
          "text": "<p><span style=\"font-size:12.0pt;\">Threatened Abortion</span></p>"
        },
        {
          "id": 362,
          "text": "<p><span style=\"font-size:12.0pt;\">Complete Abortion</span></p>"
        },
        {
          "id": 363,
          "text": "<p><span style=\"font-size:12.0pt;\">Incomplete Abortion</span></p>"
        },
        {
          "id": 364,
          "text": "<p><span style=\"font-size:12.0pt;\">Inevitable Abortion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26-year-old pregnant woman presents with mild vaginal bleeding at 12 weeks of gestation. On examination, the uterus corresponds to a 13-week size, the fetal heart rate is 156 beats per minute on ultrasound, and the cervix is closed. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q289454",
      "question_audio": null,
      "question_video": null,
      "map_id": 289454,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>In this scenario, vaginal bleeding is present, but the cervix remains closed and ultrasound shows a viable fetus with cardiac activity. These findings are typical of a<strong> threatened abortion</strong>, where the pregnancy is still ongoing but at risk.</p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/37E.png\">",
      "correct_choice_id": 361,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38,
      "choices": [
        {
          "id": 371,
          "text": "<p><span style=\"font-size:12.0pt;\">Levonorgestrel 0.75 mg</span></p>"
        },
        {
          "id": 372,
          "text": "<p><span style=\"font-size:12.0pt;\">Ethinyl estradiol + levonorgestrel</span></p>"
        },
        {
          "id": 373,
          "text": "<p><span style=\"font-size:12.0pt;\">Levonorgestrel 1.5 mg</span></p>"
        },
        {
          "id": 374,
          "text": "<p><span style=\"font-size:12.0pt;\">Desogestrel 3 mg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 22-year-old woman presents requesting emergency contraception, 8 hours after unprotected intercourse. She prefers a single-dose option. Which of the following would be the most suitable recommendation?</span></p>",
      "unique_key": "Q289455",
      "question_audio": null,
      "question_video": null,
      "map_id": 289455,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>Levonorgestrel 1.5 mg</strong> is a suitable choice for emergency contraception in this scenario. It is a progestin-only pill that works best when taken <strong>within 72 hours</strong> of unprotected intercourse. The single-dose format makes it convenient, especially for those who prefer a <strong>one-time regimen.</strong>.</p><p><strong>Emergency Contraceptive Methods:</strong></p><br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/38E.png\"><p><strong>Explanation of other options:</strong></p><p><strong>Levonorgestrel 0.75 mg (Option A): </strong>This regimen requires two separate doses 12 hours apart, which does not meet the patient's preference for a single-pill method.</p><p><strong>Ethinyl estradiol + levonorgestrel (Option B): </strong>Though effective, this combination contains estrogen, which increases the risk of nausea and vomiting, making it less ideal for someone seeking minimal side effects.</p><p><strong>Desogestrel 3 mg (Option D):</strong> Desogestrel is not approved for emergency contraception; it is used as a daily progestin-only contraceptive rather than a post-coital option.</p>",
      "correct_choice_id": 373,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 39,
      "choices": [
        {
          "id": 381,
          "text": "<p><span style=\"font-size:12.0pt;\">Postpartum depression</span></p>"
        },
        {
          "id": 382,
          "text": "<p><span style=\"font-size:12.0pt;\">Postpartum blues</span></p>"
        },
        {
          "id": 383,
          "text": "<p><span style=\"font-size:12.0pt;\">Postpartum psychosis</span></p>"
        },
        {
          "id": 384,
          "text": "<p><span style=\"font-size:12.0pt;\">Postpartum anxiety</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old woman, 5 days after a normal vaginal delivery, presents with complaints of tearfulness, mood swings, and occasional difficulty sleeping. She denies any hallucinations, delusions, or suicidal thoughts. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q289456",
      "question_audio": null,
      "question_video": null,
      "map_id": 289456,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The presence of tearfulness, mood swings, and sleep disturbance within the first week postpartum without psychotic features is characteristic of <strong>postpartum blues.</strong></p><br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/OBGRecall02072025/39E.png\"><p><strong>Explanation of other options:</strong></p><p><strong>Postpartum anxiety (Option D): </strong>Involves excessive worry, restlessness, or panic attacks, not the emotional lability and tearfulness described, which are more typical of postpartum blues.</p>",
      "correct_choice_id": 382,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 40,
      "choices": [
        {
          "id": 391,
          "text": "<p><span style=\"font-size:12.0pt;\">Measure CA-125</span></p>"
        },
        {
          "id": 392,
          "text": "<p><span style=\"font-size:12.0pt;\">Repeat USG after 6-12 weeks</span></p>"
        },
        {
          "id": 393,
          "text": "<p><span style=\"font-size:12.0pt;\">Surgical intervention</span></p>"
        },
        {
          "id": 394,
          "text": "<p><span style=\"font-size:12.0pt;\">MRI pelvis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26-year-old woman P1L1 presents with lower abdominal pain. She has a history of rheumatic heart disease and underwent mitral valve replacement, for which she takes Warfarin 3 mg daily. On examination, a mass corresponding to 14 weeks' gestational size is palpated in the abdomen. Pelvic ultrasound reveals a unilocular, thin-walled, 8 x 6 cm cyst with a reticular pattern in the left ovary. What is the next best step in management?</span></p>",
      "unique_key": "Q289457",
      "question_audio": null,
      "question_video": null,
      "map_id": 289457,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The ultrasound shows a simple, unilocular ovarian cyst in a reproductive-age woman, suggestive of a <strong>functional ovarian cyst</strong>, which typically resolves on its own. Hence, <strong>repeating the ultrasound after 6-12 weeks</strong> is the appropriate next step to assess for resolution or persistence.</p><p><strong>Functional Ovarian Cysts:</strong></p><ul><li><strong>Origin: </strong>Develop from ovarian follicles during the process of follicular maturation and ovulation.</li><li><strong>Types:</strong><ul><li><strong>Single Cysts:</strong><ul><li>Most common type</li><li>Includes <strong>follicular</strong> or <strong>corpus luteum</strong> cysts</li></ul></li><li><strong>Multiple Cysts:</strong><ul><li>Seen in conditions such as:<ul><li>Polycystic Ovary Syndrome (PCOS)</li><li>Ovarian Hyperstimulation Syndrome (OHSS)</li><li>FSH-secreting pituitary adenomas</li></ul></li></ul></li></ul></li><li><strong>Key Features:</strong><ul><li>Usually measure <strong>3-7 cm</strong> in size</li><li>Cysts larger than <strong>10 cm</strong> or persisting beyond <strong>3 months</strong> need evaluation for possible malignancy</li><li>Related to hormonal fluctuations</li><li>Contains clear fluid (may be hemorrhagic in some cases)</li><li>Generally <strong>benign</strong> and often <strong>asymptomatic</strong></li><li>Many resolve spontaneously</li></ul></li><li><strong>Management:</strong><ul><li><strong>Observation: </strong>Most resolve on their own within <strong>4-6 months</strong></li><li><strong>Follow-up: </strong>Ultrasound monitoring at <strong>6-12 weeks</strong> for persistent or growing cysts</li><li><strong>Symptomatic Treatment: </strong>Combined oral contraceptives (COCs) for pain relief or menstrual irregularities</li><li><strong>Surgical Intervention:</strong><ul><li>Indicated for cysts:<ul><li>Larger than <strong>10 cm</strong></li><li>Persistent beyond the expected timeframe</li><li>Causing significant symptoms (e.g., pain, torsion)</li></ul></li></ul></li></ul></li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Measure CA 125 levels (Option A): </strong>CA-125 is a tumor marker with poor specificity in premenopausal women. It can be elevated in benign conditions like menstruation or endometriosis, leading to unnecessary anxiety.</p><p><strong>Surgical intervention (Option C):</strong> Surgery is reserved for persistent cysts, large cysts (&gt;10 cm), complex cysts, or those causing acute complications like torsion.</p><p><strong>MRI pelvis (Option D): </strong>MRI is used when ultrasound findings are unclear or suggest complex pathology, which is not the case here, as the cyst is simple and unilocular.</p>",
      "correct_choice_id": 392,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}